Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|September 1, 1993
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidimeW Paulfeuerborn, H J Müller, K Borner, et al.
Pneumologie (Stuttgart, Germany)|October 1, 1996
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases]R Erbes, A Wagner, T Schaberg, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Quinolone pharmacokinetics and metabolismH Lode, G Höffken, M Boeckk, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1989
[Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients]F Müller, M Hund, J Löhr, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteersA Lubasch, S Ziege, B Brodersen, et al.
Chemotherapy|January 1, 1985
Biliary elimination of apalcillin in cholecystectomized patientsB M Harnoss, C M Harnoss, K Borner, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteersM Boeckh, H Lode, K Borner, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|May 1, 1986
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluidsK Borner, H Lode, G Höffken, et al.
Klinische Wochenschrift|August 16, 1991
Fibrin degradation product D-dimer in the diagnosis of pulmonary embolismJ Lichey, I Reschofski, T Dissmann, et al.
Pageof 24